Australian Government

Federal Register of Legislation

National Health (Highly Specialised Drugs Program) Special Arrangement 2021

In force

Administered by

Department of Health and Aged Care

This item is authorised by the following title:

National Health Act 1953

Latest version

F2025C00400 (C49)

01 April 2025 - 30 April 2025

Table of contents

Part 1—Preliminary
Part 2—Special arrangement supplies of HSD pharmaceutical benefits
Part 3—Payment for special arrangement supplies of HSD pharmaceutical benefits
- Division 1—Supplies by approved hospital authorities for public hospitals
  - 28 Rates of payment for approved hospital authorities for public hospitals (Act s 99(4))
  - 29 Dispensed price for approved hospital authorities for public hospitals
- Division 2—Supplies by other approved suppliers
Part 3A—Supply to CTG registered patients by CTG suppliers
- 34A Application of this Part
- 34B Application of the CTG Special Arrangement—co payment and payment etc.
Part 4—Claims for payment for special arrangement supplies of HSD pharmaceutical benefits
- 35 Rules for providing information about supplies—definition of under co payment data
- 35A Claim for payment if an eligible patient is a CTG registered patient
Part 5—Miscellaneous
- 36 Compliance and audit arrangements
- 37 Value for safety net purposes for supplies
Part 6—Application, saving and transitional provisions
Schedule 1—HSD pharmaceutical benefits and related information
- 1 Highly specialised drugs and HSD pharmaceutical benefits
Schedule 2—Maximum quantities and repeats for certain HSD pharmaceutical benefits
- 1 Maximum quantity or number of units and maximum number of repeats
Schedule 3—Circumstances and purposes
- 1 Circumstances and purposes
- Endnotes